Wnt Expression and β-Catenin in Dupuytren's Disease
Author Information
Author(s): O'Gorman David B, Wu Yan, Seney Shannon, Zhu Rebecca D, Gan Bing Siang
Primary Institution: University of Western Ontario
Hypothesis
Are changes in Wnt expression responsible for the dysregulation of β-catenin in Dupuytren's Disease?
Conclusion
Wnt expression changes are unlikely to cause the observed dysregulation of β-catenin in Dupuytren's Disease.
Supporting Evidence
- 13 Wnts were identified in both Dupuytren's Disease and control tissues.
- Wnt 11 mRNA was consistently down-regulated in disease tissue.
- Expression levels of Wnt 10b were significantly lower in Dupuytren's Disease samples.
Takeaway
The study looked at how certain proteins called Wnts behave in a hand disease, but found that they don't seem to be the reason for the problems with another protein called β-catenin.
Methodology
The study used Affymetrix Microarray analysis, RT-PCR, and Real Time PCR to assess Wnt expression in surgical specimens.
Potential Biases
Potential biases in sample selection and analysis methods could affect results.
Limitations
The study's findings may not apply to all patients due to variability in individual responses.
Participant Demographics
Patients with Dupuytren's Disease and control samples from individuals without the disease.
Statistical Information
P-Value
0.038 for Wnt 10b, 0.014 for Wnt 11
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website